Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9085 |
High Similarity |
NPD2801 |
Approved |
0.9026 |
High Similarity |
NPD3817 |
Phase 2 |
0.875 |
High Similarity |
NPD1512 |
Approved |
0.8654 |
High Similarity |
NPD1934 |
Approved |
0.8618 |
High Similarity |
NPD1511 |
Approved |
0.8608 |
High Similarity |
NPD3882 |
Suspended |
0.8562 |
High Similarity |
NPD5494 |
Approved |
0.8509 |
High Similarity |
NPD1247 |
Approved |
0.8466 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8466 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8443 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8365 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8293 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8278 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8258 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8253 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8225 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8214 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8204 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8166 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD919 |
Approved |
0.8155 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8075 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8047 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8025 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7974 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7927 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7879 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7862 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7727 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7707 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7662 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7662 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7654 |
Intermediate Similarity |
NPD920 |
Approved |
0.7651 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7597 |
Intermediate Similarity |
NPD943 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7531 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7442 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7438 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7414 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7349 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7345 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7338 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7299 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7288 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7261 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7212 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7212 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD6386 |
Approved |
0.716 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7158 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD37 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7114 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7093 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7093 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7093 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7088 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7066 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7049 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7032 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1203 |
Approved |
0.703 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7021 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6989 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6974 |
Remote Similarity |
NPD17 |
Approved |
0.6954 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6948 |
Remote Similarity |
NPD1608 |
Approved |
0.6948 |
Remote Similarity |
NPD9717 |
Approved |
0.6946 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6937 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6918 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6918 |
Remote Similarity |
NPD3268 |
Approved |
0.6911 |
Remote Similarity |
NPD6780 |
Approved |
0.6911 |
Remote Similarity |
NPD6782 |
Approved |
0.6911 |
Remote Similarity |
NPD6777 |
Approved |
0.6911 |
Remote Similarity |
NPD6781 |
Approved |
0.6911 |
Remote Similarity |
NPD6779 |
Approved |
0.6911 |
Remote Similarity |
NPD6778 |
Approved |
0.6911 |
Remote Similarity |
NPD6776 |
Approved |
0.6905 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD3146 |
Approved |
0.6903 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD2353 |
Approved |
0.689 |
Remote Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.6883 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6879 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6875 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6871 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6868 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6859 |
Remote Similarity |
NPD3225 |
Approved |
0.6846 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6845 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6839 |
Remote Similarity |
NPD3972 |
Approved |
0.6839 |
Remote Similarity |
NPD4288 |
Approved |
0.6833 |
Remote Similarity |
NPD2163 |
Approved |
0.6826 |
Remote Similarity |
NPD2354 |
Approved |
0.6826 |
Remote Similarity |
NPD3887 |
Approved |
0.6815 |
Remote Similarity |
NPD2797 |
Approved |
0.6813 |
Remote Similarity |
NPD411 |
Approved |
0.6807 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6804 |
Remote Similarity |
NPD7697 |
Approved |
0.6804 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6804 |
Remote Similarity |
NPD7698 |
Approved |
0.6804 |
Remote Similarity |
NPD7435 |
Discontinued |
0.68 |
Remote Similarity |
NPD5019 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD9268 |
Approved |
0.6792 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.679 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6774 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6774 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6769 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6769 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6766 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6761 |
Remote Similarity |
NPD6971 |
Discontinued |
0.674 |
Remote Similarity |
NPD7228 |
Approved |
0.6739 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6737 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6737 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6733
|
Remote Similarity |
NPD5283 |
Phase 1 |